The first biologic agent approved by US FDA for the treatment of psoriasis is:: (A) Alefacept, (B) Efalizumab, (C) Etanercept, (D) Infliximab
Answer is A. In 2003, Alefacept became the first biological agent to be licensed for the treatment of severe psoriasis. Alefacept is a T-cell inhibitor - binds to CD-2 Infliximab, Etanercept- are TNF-a inhibitor Efalizumab is a T-cell inhibitor binds to CD-11